Quoin Pharmaceuticals, Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Quoin Pharmaceuticals, Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.95M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($3.70M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.70M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.81M) | May 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($3.81M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($3.81M) | Nov 6, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.35M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($1.97M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($1.97M) | Nov 6, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($2.33M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($2.33M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($2.33M) | May 13, 2025 |
| Q2 | 2023 | Sep 30, 2023 | ($1.93M) | Nov 9, 2023 |
| Q3 | 2024 | Sep 30, 2023 | ($1.93M) | Nov 8, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.11M) | Aug 8, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($2.11M) | Nov 8, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($2.60M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.60M) | May 9, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($2.60M) | Nov 8, 2024 |
| Q2 | 2023 | Sep 30, 2022 | ($3.03M) | Nov 9, 2023 |